New data show improved outcomes in resectable pancreatic cancer with PAXG chemotherapy over standard mFOLFIRINOX, but should ...

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

Team awarded $2.5 million grant to develop system for inserting tiny light-emitting fibers directly into tumors.

In the phase 3 PANOVA-3 trial, patients who underwent tumor-treating fields therapy had extended overall survival vs standard ...

Actuate Therapeutics (NASDAQ:ACTU) on Saturday announced encouraging results from a Phase 2 clinical trial testing its ...

Amgen's Nplate proves highly effective in preventing thrombocytopenia from chemotherapy, enabling full-dose cancer treatment ...

Pharmacists have warned that "one of the worst" examples of medicine shortages is affecting cancer patients. Creon, a ...

The team developed a tumor-independent test that is used to evaluate genome-wide cell-free DNA fragmentation profiles and repeat landscapes.

Cancer therapies can cause a broad spectrum of cardiovascular diseases,” said Joerg Herrmann, MD, a cardio-oncologist at the ...